Viewing StudyNCT04878211



Ignite Creation Date: 2024-05-06 @ 4:06 PM
Last Modification Date: 2024-10-26 @ 2:04 PM
Study NCT ID: NCT04878211
Status: TERMINATED
Last Update Posted: 2024-06-20
First Post: 2021-05-03

Brief Title: A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Relapsing Multiple Sclerosis RMS
Keywords:
Name View
Multiple Sclerosis View
Relapsing Multiple Sclerosis View
COVID View
COVID-19 View
Vaccine View
Coronavirus View
adult View
OMB157 View